期刊文献+

舟山眼镜蛇毒蕈碱样多肽MP的部分理化性质测定 被引量:1

Biochemical characterization of the muscarinic peptide isolated from Naja atra venom
下载PDF
导出
摘要 目的对舟山眼镜蛇毒蕈碱样多肽MP成分进行纯化及部分理化性质测定。方法采用色谱技术纯化蛇毒MP成分,质谱仪测定其相对分子质量(Mr);Edman降解法分析部分氨基酸序列,与已知成分比对;以卵磷脂为底物测定MP组分的磷脂酶A2活性;采用Bliss法测定MP对小鼠的急性毒性。结果 MP的Mr为13 260,其N端16位氨基酸序列为NLYQFKNMIQCTVPSR,与已知蛇毒磷脂酶A2基本一致,并具有较强的磷脂酶A2活性;腹腔注射MP对小鼠的LD50值为14.3 mg/kg。结论 MP为一种眼镜蛇毒磷脂酶A2。 Purpose To identify the property of the fraction of muscarinic peptide(MP) isolated from Naja atra venom by purifying and determining the biochemical charaterization. Methods MP was purified by column chromatography. Its molecular weight was determined by mass spectrometry. The partial amino acid sequence of MP was gained by Edman degradation analysis. Lecithin as substrate was used to meas- ure phospholipase A2 activity of MP. Bliss method was used to determine the acute toxicity of MP in mice. Results The molecular weight of MP was 13 260 D and its N-terminal 16 amino acid sequence was NLYQFKNMIQCTVPSR,which is consistent with the known venom phospholipase A2. MP also displayed a strong phospholipase A2 activity. The LD50 value was 14.3 mg/kg in mice by intraperitoneal injection of MP. Conclusion It is suggested that MP is a snake venom phospholipase A2.
出处 《中国生化药物杂志》 CAS CSCD 北大核心 2012年第6期725-727,731,共4页 Chinese Journal of Biochemical Pharmaceutics
基金 福建省青年科技人才创新项目资助(2008F3084)
关键词 眼镜蛇毒 毒蕈碱样多肽 磷脂酶A2 理化性质 cobra venom muscarinic peptide phospholipase A2 biochemical characterization
  • 相关文献

参考文献13

  • 1Jerusalinsky D, Kornisiuk E, Alfaro P, et al. Muscarinic toxins : no- vel pharmacological tools for the muscarinic cholinergic system [ J ]. Toxicon ,2000,38 ( 6 ) :747-761.
  • 2Miyoshi S,Tu T A. Phospholipase A2 from Naja naja sputatrix ven- om is a muscarinic acetylcholine receptor inhibitor [J].Arch Bio- chem Biophys,1996,328 ( 1 ) :17-25.
  • 3Miyoshi S,Tu T A. A snake venom inhibitor to muscarinic acetylcho- line receptor)mAChR) :isolation and interaction with cloned human mAChR [ J ]. Arch Biochem Biophys ,2000,377 ( 2 ) :290-295.
  • 4郑佳冰,黄立峰,许盈,俞昌喜.舟山眼镜蛇毒蕈碱样多肽的分离及其对M胆碱受体的激动效应[J].福建医科大学学报,2007,41(1):1-4. 被引量:1
  • 5Jolkkonen M, Van Giersbergen L P, Helhnan U, et al. Muscarinic toxins from the black mamba Dendroaspis polylepis[J]. Eur J Bio- chem, 1995,234(2) :579-585.
  • 6Kukhtina V V ,Weise C ,Muranova A T,et al. Muscarinic toxin-like proteins from cobra venom [ J ]. Eur J Biochem, 2000,267 ( 23 ) : 6784-6789.
  • 7Bradley K N. Musearinie toxins from the green mamba[J]. Phar- maeol Ther, 2000,85 ( 2 ) : 87-109.
  • 8陈思锋,吴中立.体液和组织磷脂酶A_2简便快速测定法[J].第二军医大学学报,1989,10(3):254-256. 被引量:210
  • 9Adem A,Asblom A, Johansson G, et al. Toxins from the venom of the green mamba Dendroaspis angusticeps that inhibit the binding of quinuclidinyl benzilate to muscarinic acetylcholine receptors[ J ]. Biochim Biophys Acta, 1988,968 ( 3 ) : 340-345.
  • 10Fruchart G C,Mourier G, Marquer C, et al. How three-finger-fold toxins interact with various eholinergic receptors [ J ], J Mol Neuros- ei ,2006,30 ( 1-2 ) :7-8.

二级参考文献13

  • 1沃格尔HG 沃格尔WH.药理学实验指南--新药发现和药理学评价[M].北京:科学出版社,2001.35-36.
  • 2Meier J,Theakston RDG.Approximate LD50determinations of snake venoms using eight to ten experiment at animals[J].Toxicon,1986,24(4):395-401.
  • 3萨姆布鲁克 J,弗里奇 E F,曼尼阿蒂斯 T.分子克隆实验指南[M].2版.金冬雁,黎孟枫,译.北京:科学出版社,1992.
  • 4Jolkkonen M,Giersbergen P L V,Hellman U,et al.Muscarinic toxins from the black mamba Dendroaspis polylepis[J].Eur J Biochem,1995,234:579-585.
  • 5Vandermeers A,Vandermeers-Piret M C,Rathe J,et al.Purification and sequence determination of a new muscarinic toxin(MT4) from the venom of the green mamba(Dendroaspis angusticeps)[J].Toxicon,1995,33:1171-1179.
  • 6Bradley K N.Muscarinic toxins from the green mamba[J].Pharmacol Ther,2000,85:87-109.
  • 7Miyoshi S,Tu AT.Phospholipase A2 from Naja naja sputatrix venom is a muscarinic acetylcholine receptor inhibitor[J].Arch Biochem Biophys,1996,328:17-25.
  • 8Adem A,Karlsson E.Muscarinic receptor subtype selective toxins[J].Life Sci,1997,60:1069-1076.
  • 9Jerusalinsky D,Cervenansky C,Abo V,et al.Muscarinic cholinergic toxins from Dendroaspis angusticeps venom[J].J Neurochem,1991,57(Suppl):93.
  • 10Jerusalinsky D,Cervenansky C,Walz R,et al.A peptide muscarinic toxin from the green mamba venom shows agonist-like action in an inhibitory avoidance learning task[J].Eur J Pharmacol,1993,240:103-105.

共引文献211

同被引文献76

  • 1Wu Y, Jin Y, Li Y, et al. NIR spectroscopy as a process analytical technology (PAT) tool for on-line and real-time monitoring of an extraction process[J]. Vib Spectrosc,2012,5 8 :109-118.
  • 2Xu B,Wu Z S,Lin Z Z,et al. NIR analysis for batch process of ethanol precipitation coupled with a new calibration model updating strategy[J]. Anal ChimActa, 2012, 720 ( 30 ) :2-28.
  • 3Dai J, Wang G, Li W, et al. High-throughput screening for anti-influenza A virus drugs and study of the mechanism of procyanidin on influenza A virus-induced autophagy[J]JBiomolScreen, 2012, 17(5): 605-617.
  • 4Liu C,Wang L,Xu Z,et al. A multilayer microdevice for cell-based high- throughput drug screening[J]. J Micromech Microeng, 2012,22 (6): 065008.
  • 5Li D,Wang M,Yang C,et al. Solid state characterizations and analysis of stability in azelnidipine polymorphs[J]. Chem Pharm Bull,2012,60( 8): 995-1002.
  • 6Yuan Y Z, Zhang M, Fan X L,et al. Impurity profiling of etimicin sulfate by liquid chromatography ion-trap mass spectrometry[J]. J Pharm B iomed Anal,2012,70:212-223.
  • 7Wang X, Zhou H, Zheng J, et al. Identification and character zation of four process-related impurities in retigabine[J]. J Pharm Biomed Anal, 2012,71:148-151.
  • 8Liu C H,Lu D D,Deng X X,et al.The analysis of major impurities of lipophilic-conjugated phosphorothioate oligonucleotides by ion- pair reversed-phase HPLC combined with MALDI-TOF-MS[J]. Anal Bioanal Chem,2012,403(5): 1333-1342.
  • 9Wang B L,Wang H,Wang E,et al.lsolation and structure characterizationof related impurities in Sodium Tanshinone IIA Sulfonate by LC/ESI- MSn and NMR[J] d Pharm B iomed Anal,2012,67/68:36-41.
  • 10Gao T, Liu Y X,Ji Y B,et al. Structural elucidation of impurities in 5-n-butyl-4- {4-[2-( 1H-tetrazole-5-yl)- 1H-pyrrol- 1 -yl]phenylmethyl } - 2,4-dihydro-2-(2,6-dichlorophenyl)-3H-l,2,4-triazol-3-one (Ib), a novel nonpeptide a ngiotensin AT receptor antagonist[J]. J Pharm Biomed Anal, 2012,66:81-386.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部